| Samsung Bioepis CH GmbH - Imraldi 40 mg/0.4 ml, Injektionslösung in einer Fertigspritze |
| 67427 | | 02 | | Imraldi 40 mg/0.4 ml | | Injektionslösung in einer Fertigspritze | | L04AB04 | | Adalimumab | | 18.12.2024 | | |
|
| Composition |
| adalimumabum 40 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, acidum succinicum, dinatrii succinas, histidinum, histidini hydrochloridum monohydricum, mannitolum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 0.08 mg. |
| Packungsbestandteile |
| Injektionslösung in Fertigspritze | | | | | | | | Active Agent | Dose |
|---|
| Adalimumabum | 40mg / 0.4ml |
| | BAG: Active Agent | Dose |
|---|
| Adalimumabum | 40 mg |
| | | | Inactive agents |
|---|
| Acidum Succinicum | | Dinatrii Phosphas Heptahydricus | | Dinatrii Succinas | | Histidini Hydrochloridum Monohydricum | | Histidinum | | Mannitolum | | Natrii Dihydrogenophosphas Monohydricus | | Polysorbatum 20 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | | 371.10 | 419.95 | B | SL | No | | 005 | 2 | 742.20 | 823.50 | B | SL | No | | 006 | 6 | 2080.98 | 2281.00 | B | SL | No |
|
